A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
Clinical trial NCT00002059 · COMPLETED
Trial details
- NCT number
- NCT00002059
- Sponsor
- Newport Pharmaceuticals International
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.